THIS THE BOTTOM LINE FOLKS: 1. Compare ENDV's market cap

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
909
THIS THE BOTTOM LINE FOLKS:

1. Compare ENDV's market cap with it's peers, such as, PLS$ and MEOBF
2. The president keeps buying and buying in the open market, he now has approximately little over 21
million shares. Remember the insiders can sell for number of reasons, but they buy for one reason.
So, what is that one reason again?
3. Many catalyst just for this year alone, serious consideration to uplift to the National Exchange as
per press release, we should also get the trial results for the heart by end of June 2017.
4. Other indication results should be announced before the end of the year
5. Big bio-pharma companies are already looking into investing in this sector, which some have
already. Also, big name tech companies have already started looking into the sector as well, such
as Tesla, Apple, and Google.

Ask yourself this question, why does the president keep buying and buying? Ask yourself this question, why does big bio-pharma invest in PLS$? Why does Tesla, Apple, and Google, just to name a few, getting into the technology as well? More importantly, why does the president of the company keeps buying and buying in the open market if the trials were a failure? Even, more important than that, why does the president and the CEO defer their salaries to the tune of 1.8 million dollars each?I've answered all the question plus more and all I see is DOLLARS AND DOLLARS

Endonovo Therapeutics, Inc. (ENDV) Stock Research Links

ENDV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

8x8, Inc. Achieves Earnings Beat with Strong Future Guidance

Updated Category News Views 91

8x8, Inc. Reports Strong Earnings Amid Growth Initiatives 8x8, Inc. (NASDAQ: EGHT), the prominent cloud communications provider, has experienced a notable uptick of 2% in its share value during after-hours trading following the release of their latest quarterly earnings. The company reported second quarter results that exceeded market expectations, providing a boost in...

Continue Reading
Investors Can Take Action in Indivior PLC Fraud Case Today

Updated Category News Views 73

Investors Encouraged to Join Indivior PLC Securities Fraud Lawsuit The Schall Law Firm, a well-known litigation firm dedicated to protecting shareholders' rights, is reaching out to investors about an important class action lawsuit against Indivior PLC (NASDAQ: INDV). This case concerns potential breaches of the Securities Exchange Act of 1934 and Rule 10b-5 as...

Continue Reading
McDermott Expands Board with New Strategic Leaders

Updated Category News Views 286

McDermott Strengthens Leadership with New Board Appointments McDermott International, Ltd has made a significant strategic move by announcing the addition of two accomplished professionals, Michael Martino and Farhad Nanji, to its Board of Directors. This change is aimed at bolstering the company’s leadership as it navigates the complex landscapes of the energy...

Continue Reading
United Therapeutics Achieves Record Stock Price of $366.23

Updated Category News Views 52

United Therapeutics Reaches New Heights in Stock Value United Therapeutics Corporation (NASDAQ: UTHR) has achieved a remarkable milestone by reaching an all-time high of $366.23. This significant increase signifies a robust period of growth for the biotech company, which has seen its stock jump by an impressive 54.22% over the past year. The surge is largely attributed to...

Continue Reading
DoorDash Surges to New Heights as Growth Strategies Flourish

Updated Category News Views 303

DoorDash Reaches New Stock Heights DoorDash (NASDAQ: DASH) has experienced a remarkable surge, with its stock recently hitting a 52-week high of $181.78. This leap signifies not only a thriving business model but also a considerable increase in investor confidence in the food delivery service. With a market cap of $75.3 billion, DoorDash has shown impressive growth with a...

Continue Reading